Skip to main content

Table 2 Onset age and correlation with AML of reviewed myeloid sarcoma patients

From: Vulvar myeloid sarcoma as the presenting symptom of acute myeloid leukemia: a case report and literature review of Chinese patients, 1999–2018

MS siteOnset Age (year)Without AMLPreceding AMLCoinciding with AMLAML Relapse
Vulva25–78 (49.5 ± 9.3)1 (16.7%)1 (16.7%)4 (66.7%)
Vagina55–61 (58 ± 3)1 (100%)
Uterine cervix23–63 (41.3 ± 2.2)10 (58.8%)4 (23.5%)2 (11.8%)1 (5.9%)
Uterine body33–44 (38.3 ± 3.2)3 (100%)
Ovary22–36 (27.5 ± 1.4)8 (66.7%)1 (8.3%)1 (8.3%)2 (16.7%)
Multifocal25–51 (40.1 ± 2.8)5 (62.5%)1 (12.5%)2 (25%)
Total22–78 (39.2 ± 1.7)28 (59.6%)7 (14.9%)7 (14.9%)5 (10.6%)
  1. AML acute myeloid leukemia